ClinConnect ClinConnect Logo
Search / Trial NCT05408741

A Pilot Study Assessing the Effectiveness of Use of Guided Imagery for Treatment of Pain and Symptom Management in Women With Post-mastectomy Pain Syndrome

Launched by M.D. ANDERSON CANCER CENTER · Jun 2, 2022

Trial Information

Current as of May 03, 2025

Completed

Keywords

ClinConnect Summary

OBJECTIVES:

Primary objective:

-To evaluate the effectiveness of use of Guided imagery and deep breathing techniques in pain management compared to control arm in patients with post-mastectomy pain syndrome who don't receive intervention and only receive standard care.

Secondary objective:

To evaluate effectiveness of Guided imagery and deep breathing techniques in symptom cluster management including fatigue, sleep, depression, and anxiety and in general quality of life compared to control arm who don't receive intervention and only receive standard care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Breast Cancer patients who were performed mastectomy in previous 12 months
  • 2. Post-mastectomy pain syndrome \>4 weeks.
  • 3. Patients who report 2-10 on the baseline pain severity score or 2-10 on the baseline pain interference score
  • 4. Patients ≥ 18 years old and ≤ 70 years old
  • 5. Must understand and read English, sign a written informed consent, and follow protocol requirements
  • 6. If on medication for anxiety or depression, stable dose of medications for management of anxiety or depression symptoms for at least six weeks prior to enrollment with no plans to change medications in the subsequent four weeks. Increases or decreases allowed within drug class, but changing drug class will make patient in-evaluable
  • Exclusion Criteria:
  • 1. Pending surgery during treatment
  • 2. Suicidal ideation
  • 3. Diagnosis of a formal thought disorder (e.g., schizophrenia)

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Uzondu Osuagwu, MD

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials